Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno
Stephan Windecker

Showing results (141-150 of 2,159) with videos related to

Pageof 216
Sort By:
Journal of Thoracic Disease|December 23, 2017
Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?Islam Y Elgendy, Davide Capodanno
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 19, 2016
Upcoming TAVI trials: rationale, design and impact on clinical practiceDavide Capodanno, Martin B Leon
JACC. Cardiovascular Interventions|July 25, 2020
Stent Wars: Coated Stents Strike BackDavide Capodanno, Marco Angelo Monte
Circulation Journal : Official Journal of the Japanese Circulation Society|March 16, 2018
Current Use of Intracoronary Imaging in Interventional Practice　- Results of a European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Japanese Association of Cardiovascular Interventions and Therapeutics (CVIT) Clinical Practice SurveyKonstantinos C Koskinas, Masato Nakamura, Lorenz Räber, et al.
Expert Review of Clinical Pharmacology|December 28, 2024
Gene therapy in cardiology: pioneering a new era in medical ethics and patient careMaria Sara Mauro, Davide Capodanno
Thrombosis and Haemostasis|February 24, 2025
Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding RiskMaria Sara Mauro, Davide Capodanno
The New England Journal of Medicine|January 22, 2025
Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XIDominick J Angiolillo, Davide Capodanno
Journal of the American College of Cardiology|June 12, 2012
Targeting platelet nitric oxide resistance with ramipril: unraveling mechanisms of atherothrombotic risk reduction with angiotensin-converting enzyme inhibitorsDominick J Angiolillo, Davide Capodanno
Giornale Italiano Di Cardiologia (2006)|March 6, 2020
[Pharmacological strategy pre- and post-percutaneous coronary intervention in patients with acute coronary syndrome on oral anticoagulation therapy]Antonio Gabriele Franchina, Davide Capodanno
Expert Opinion on Biological Therapy|December 22, 2017
Canakinumab for secondary prevention of atherosclerotic diseaseDavide Capodanno, Dominick J Angiolillo
Pageof 216

Showing results (141-150 of 2,159) with videos related to

Sort By:
Pageof 216
Journal of Thoracic Disease|December 23, 2017
Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?Islam Y Elgendy, Davide Capodanno
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 19, 2016
Upcoming TAVI trials: rationale, design and impact on clinical practiceDavide Capodanno, Martin B Leon
JACC. Cardiovascular Interventions|July 25, 2020
Stent Wars: Coated Stents Strike BackDavide Capodanno, Marco Angelo Monte
Circulation Journal : Official Journal of the Japanese Circulation Society|March 16, 2018
Current Use of Intracoronary Imaging in Interventional Practice　- Results of a European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Japanese Association of Cardiovascular Interventions and Therapeutics (CVIT) Clinical Practice SurveyKonstantinos C Koskinas, Masato Nakamura, Lorenz Räber, et al.
Expert Review of Clinical Pharmacology|December 28, 2024
Gene therapy in cardiology: pioneering a new era in medical ethics and patient careMaria Sara Mauro, Davide Capodanno
Thrombosis and Haemostasis|February 24, 2025
Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding RiskMaria Sara Mauro, Davide Capodanno
The New England Journal of Medicine|January 22, 2025
Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XIDominick J Angiolillo, Davide Capodanno
Journal of the American College of Cardiology|June 12, 2012
Targeting platelet nitric oxide resistance with ramipril: unraveling mechanisms of atherothrombotic risk reduction with angiotensin-converting enzyme inhibitorsDominick J Angiolillo, Davide Capodanno
Giornale Italiano Di Cardiologia (2006)|March 6, 2020
[Pharmacological strategy pre- and post-percutaneous coronary intervention in patients with acute coronary syndrome on oral anticoagulation therapy]Antonio Gabriele Franchina, Davide Capodanno
Expert Opinion on Biological Therapy|December 22, 2017
Canakinumab for secondary prevention of atherosclerotic diseaseDavide Capodanno, Dominick J Angiolillo
Pageof 216